184 related articles for article (PubMed ID: 19641159)
1. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.
Piemonti L; Calori G; Lattuada G; Mercalli A; Ragogna F; Garancini MP; Ruotolo G; Luzi L; Perseghin G
Diabetes Care; 2009 Nov; 32(11):2105-10. PubMed ID: 19641159
[TBL] [Abstract][Full Text] [Related]
2. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.
Piemonti L; Calori G; Mercalli A; Lattuada G; Monti P; Garancini MP; Costantino F; Ruotolo G; Luzi L; Perseghin G
Diabetes Care; 2003 Oct; 26(10):2883-9. PubMed ID: 14514596
[TBL] [Abstract][Full Text] [Related]
3. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory markers in women with a recent history of gestational diabetes mellitus.
Di Benedetto A; Russo GT; Corrado F; Di Cesare E; Alessi E; Nicocia G; D'Anna R; Cucinotta D
J Endocrinol Invest; 2005 Jan; 28(1):34-8. PubMed ID: 15816369
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Ding D; Su D; Li X; Li Z; Wang Y; Qiu J; Lin P; Zhang Y; Guo P; Xia M; Li D; Yang Y; Hu G; Ling W
PLoS One; 2015; 10(3):e0120633. PubMed ID: 25786118
[TBL] [Abstract][Full Text] [Related]
8. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
Floris-Moore M; Fayad ZA; Berman JW; Mani V; Schoenbaum EE; Klein RS; Weinshelbaum KB; Fuster V; Howard AA; Lo Y; Schecter AD
AIDS; 2009 May; 23(8):941-9. PubMed ID: 19318907
[TBL] [Abstract][Full Text] [Related]
9. Diets high in total antioxidant capacity improve risk biomarkers of cardiovascular disease: a 9-month observational study among overweight/obese postmenopausal women.
Wang Y; Yang M; Lee SG; Davis CG; Koo SI; Fernandez ML; Volek JS; Chun OK
Eur J Nutr; 2014 Sep; 53(6):1363-9. PubMed ID: 24343299
[TBL] [Abstract][Full Text] [Related]
10. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
11. Novel biomarkers of cardiometabolic risk are associated with plasma glucose within non-diabetic range. The Brazilian Longitudinal Study of Adult Health - ELSA-Brasil.
Almeida-Pititto B; Ribeiro-Filho FF; Lotufo PA; Bensenor IM; Ferreira SR
Diabetes Res Clin Pract; 2015 Jul; 109(1):110-6. PubMed ID: 25958099
[TBL] [Abstract][Full Text] [Related]
12. Influence of type 2 diabetes mellitus on cardiovascular disease mortality: findings from the Hawaii-Los Angeles-Hiroshima study.
Imazu M; Sumii K; Yamamoto H; Toyofuku M; Tadehara F; Okubo M; Yamakido M; Kohno N; Onaka AT;
Diabetes Res Clin Pract; 2002 Jul; 57(1):61-9. PubMed ID: 12007731
[TBL] [Abstract][Full Text] [Related]
13. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Sabatine MS; Murphy SA; Gibson CM; Antman EM; McCabe CH; Cannon CP; Braunwald E
Circulation; 2003 Feb; 107(5):690-5. PubMed ID: 12578870
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects.
Kong C; Elatrozy T; Anyaoku V; Robinson S; Richmond W; Elkeles RS
Diabetes Metab Res Rev; 2000; 16(6):448-53. PubMed ID: 11114104
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Sozer V; Himmetoglu S; Korkmaz GG; Kaya S; Aydin S; Yumuk V; Hatemi H; Uzun H
Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
[TBL] [Abstract][Full Text] [Related]
16. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
18. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.
Georgakis MK; Malik R; Björkbacka H; Pana TA; Demissie S; Ayers C; Elhadad MA; Fornage M; Beiser AS; Benjamin EJ; Boekholdt SM; Engström G; Herder C; Hoogeveen RC; Koenig W; Melander O; Orho-Melander M; Schiopu A; Söderholm M; Wareham N; Ballantyne CM; Peters A; Seshadri S; Myint PK; Nilsson J; de Lemos JA; Dichgans M
Circ Res; 2019 Sep; 125(8):773-782. PubMed ID: 31476962
[No Abstract] [Full Text] [Related]
19. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
20. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
